April 30, 2017 6:26 AM ET

Biotechnology

Company Overview of aTyr Pharma, Inc.

Key Executives for aTyr Pharma, Inc.

NameBoard RelationshipsTitleAge
John D. Mendlein Ph.D., J.D.83 RelationshipsChief Executive Officer and Director56
Paul R. Schimmel Ph.D.82 RelationshipsFounder and Director75
Xiang-Lei Yang Ph.D.No RelationshipsFounder--
John T. Blake CPANo RelationshipsSenior Vice President of Finance40
David J. King Ph.D.No RelationshipsSenior Vice President of Research57
View More Key Executives

aTyr Pharma, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
John K. Clarke 82 RelationshipsAlnylam Pharmaceuticals, Inc.62
John D. Mendlein Ph.D., J.D. 83 RelationshipsaTyr Pharma, Inc.56
Paul R. Schimmel Ph.D. 82 RelationshipsaTyr Pharma, Inc.75
James C. Blair Ph.D. 175 RelationshipsDomain Associates, L.L.C.76
Kathryn E. Falberg 71 RelationshipsThe Trade Desk, Inc.55
View All Board Members

aTyr Pharma, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Kathryn E. Falberg71 Relationships3 Executives
Compensation Committee Ph.D.James C. Blair175 Relationships3 Executives
Nominating Committee John K. Clarke82 Relationships3 Executives
Corporate Governance Committee John K. Clarke82 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$494.7K
494.7K
381.4K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$494.7K
494.7K
14.0M
Compensation as of Fiscal Year 2016
aTyr Pharma, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

TapImmune Announces Change in Management and Board of Directors
April 28, 2017 8:05 PM ET
Avalon Globocare Corp. Announces Board Appointments
April 28, 2017 8:02 PM ET
Plandai Biotechnology, Inc Appoints Ezra Jones as Vice President of Sales and Marketing
April 28, 2017 2:10 PM ET
Adamas Pharmaceuticals, Inc. Appoints Richard A. King as Chief Operating Officer
April 27, 2017 9:28 PM ET
Mast Therapeutics, Inc. Announces Management Changes
April 27, 2017 9:25 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact aTyr Pharma, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.